The patient with renal stones
Naderi, AS. and Reilly, RF Manual of Nephrology diagnosis and therapy 2007 Lippincott 80-90
The patient with disorders of serum calcium and phosphorus
Penfield, J. and Reilly, RF Manual of Nephrology diagnosis and therapy 2007 Lippincott 63-79
Fluids, Electrolytes and Acid-base Homeostasis- Instant Access
Reilly, RF., and Perazella, MA. McGraw Hill, New York, New York 2007
Phosphate, aluminum and other elements in chronic renal failure
Amanzadeh, J, Reilly, RF Diseases of the kidney and urinary tract 2005 Lippincott Chapter 102
Nephrology in 30 days
Reilly, RF, Perazella, MA McGraw-Hill 2005 Text book of Nephrology
Etiology and treatment of hypomagnesemia
Naderi, AS., Reilly, RF. Nat. Clin. Pract. Nephrol. 2008 4 80-89
Nephrogenic Systemic Fibrosis Risk: Is There a Difference between Gadolinium-Based Contrast Agents?
Penfield JG, Reilly RF. Semin. Dial. 2008 21 129-134
Risk of nephrogenic systemic fibrosis (NSF) with gadoteridol (ProHance?) in patients on chronic hemodialysis
Reilly, RF Clin. Am. Soc. Nephrol. 2008 3 747-751
Long-term sevelamer use is associated with a higher serum phosphate, higher CaxP product and lower serum bicarbonate than calcium-containing binders.
Brewster, UC., Ciampi, M., Abu-Alfa, AK., and Reilly, RF. Nephrology 2006 11 142-146
Effect of intravenous iron on hemodialysis catheter microbial colonization and blood-borne infection.
Brewster, UC, Coca, SG, Reilly, RF, Perazella, MA. Nephrology 2005 10 124-128